Original Research

Published on 30 Sep 2022

The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy

in Hematologic Malignancies

Yang Wang
Zhiqiang Song
Yuke Geng
Lei Gao
Lili Xu
Gusheng Tang
Xiong Ni
Li Chen
Jie Chen
Tao Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.987965

2,797 views
4 citations

Case Report

Published on 30 Sep 2022

Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab

in Hematologic Malignancies

Laura Ballotta
Omar Simonetti
Pierlanfranco D’Agaro
Ludovica Segat
Raffaella Koncan
Pamela Martinez-Orellana
Federica Dattola
Emanuele Orsini
Alessandro Marcello
Simeone Dal Monego

Frontiers in Oncology

doi 10.3389/fonc.2022.945060

5,359 views
6 citations

Editorial

Published on 29 Sep 2022

Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities

in Hematologic Malignancies

José A. Costoya
Francesco Piazza

Frontiers in Oncology

doi 10.3389/fonc.2022.1026315

979 views
1 citation

Original Research

Published on 29 Sep 2022

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy

in Hematologic Malignancies

Chenjiao Yao
Ruoyao Xu
Qianyuan Li
Sheng Xiao
Min Hu
Linyong Xu
Quan Zhuang

Frontiers in Oncology

doi 10.3389/fonc.2022.970544

2,368 views
1 citation

Original Research

Published on 29 Sep 2022

Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia

in Hematologic Malignancies

Oliver Schleicher
Annkathrin Horndasch
Manuela Krumbholz
Stephanie Sembill
Claudia Bremensdorfer
Desiree Grabow
Friederike Erdmann
Axel Karow
Markus Metzler
Meinolf Suttorp

Frontiers in Oncology

doi 10.3389/fonc.2022.963223

4,646 views
6 citations

Case Report

Published on 28 Sep 2022

The successful combination of grapefruit juice and venetoclax in an unfit acute myeloid leukemia patient with adverse risk: A case report

in Hematologic Malignancies

Zhangbiao Long
Min Ruan
Wei Wu
Qingshu Zeng
Qingsheng Li
Zhengqi Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.912696

2,895 views
4 citations

Original Research

Published on 27 Sep 2022

Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children’s Cancer Hospital Egypt

in Hematologic Malignancies

Mahmoud Hammad
Hanafy Hafez
Iman Sidhom
Dina Yassin
Sherine Salem
Khaled Alsheshtawi
Nayera Hamdy
Nahla Elsharkawy
Alaa Elhaddad

Frontiers in Oncology

doi 10.3389/fonc.2022.983220

2,402 views
1 citation

Review

Published on 27 Sep 2022

Targeted therapy in NPM1-mutated AML: Knowns and unknowns

in Hematologic Malignancies

Rong Wang
Pan Xu
Lin-Lin Chang
Shi-Zhong Zhang
Hong-Hu Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.972606

22,419 views
22 citations

Original Research

Published on 26 Sep 2022

An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia

in Hematologic Malignancies

Yu Liu
Ruyue Zheng
Yajun Liu
Lu Yang
Tao Li
Yafei Li
Zhongxing Jiang
Yanfang Liu
Chong Wang
Shujuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.977119

2,001 views
3 citations

Original Research

Published on 26 Sep 2022

Clinical and pathological findings in neurolymphomatosis: Preliminary association with gene expression profiles in sural nerves

in Hematologic Malignancies

Federica Cerri
Francesco Gentile
Ferdinando Clarelli
Silvia Santoro
Yuri Matteo Falzone
Giorgia Dina
Alessandro Romano
Teuta Domi
Laura Pozzi
Raffaella Fazio

Frontiers in Oncology

doi 10.3389/fonc.2022.974751

2,203 views
3 citations

Case Report

Published on 23 Sep 2022

Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene

in Hematologic Malignancies

Li Chen
Hongming Zhu
Yongmei Zhu
Wen Jin
Fangyi Dong
Jianfeng Li
Jiong Hu
Qiusheng Chen
Kankan Wang
Junmin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1013046

1,485 views

Original Research

Published on 23 Sep 2022

A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling

in Hematologic Malignancies

Yang Zhang
Zhihua Wang
Guoyu Hu
Jieping Li
Yongheng Chen
Yi Jiang
Haiying Zhong
Xianling Liu
Chunhong Hu
Honglin Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.870676

2,405 views
3 citations

Case Report

Published on 21 Sep 2022

Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy

in Hematologic Malignancies

Jingjing Deng
Yuehui Lin
Defeng Zhao
Chunrong Tong
Alex H. Chang
Wenming Chen
Wen Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.901266

4,832 views
6 citations

Original Research

Published on 21 Sep 2022

Lung microbiome in children with hematological malignancies and lower respiratory tract infections

in Hematologic Malignancies

Yun Zhang
Haonan Ning
Wenyu Zheng
Jing Liu
Fuhai Li
Junfei Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.932709

1,769 views
2 citations

Original Research

Published on 16 Sep 2022

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China

in Hematologic Malignancies

Fenghua Gao
Tingting Zhang
Xia Liu
Zhenjie Qu
Xianming Liu
Lanfang Li
Lihua Qiu
Zhengzi Qian
Shiyong Zhou
Wenchen Gong

Frontiers in Oncology

doi 10.3389/fonc.2022.863021

5,590 views
3 citations

Case Report

Published on 16 Sep 2022

Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia

in Hematologic Malignancies

Shintaro Kazama
Kazuaki Yokoyama
Toshimitsu Ueki
Hiroko Kazumoto
Hidetoshi Satomi
Masahiko Sumi
Ichiro Ito
Nozomi Yusa
Rika Kasajima
Eigo Shimizu

Frontiers in Oncology

doi 10.3389/fonc.2022.974307

4,269 views
4 citations

Navigation group

Articles

The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy

Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab

Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy

Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia

The successful combination of grapefruit juice and venetoclax in an unfit acute myeloid leukemia patient with adverse risk: A case report

Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children’s Cancer Hospital Egypt

Targeted therapy in NPM1-mutated AML: Knowns and unknowns

An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia

Clinical and pathological findings in neurolymphomatosis: Preliminary association with gene expression profiles in sural nerves

Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene

A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling

Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy

Lung microbiome in children with hematological malignancies and lower respiratory tract infections

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China

Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia